Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Introduction
Featured Profiles
Genmab
Geron
SpringWorks
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Small Cell Lung Cancer
Evolving Landscapes in Multiple Myeloma
OFS Summit
Multimedia
All Videos
Case-Based Exchanges
Voices From ASCO 2025
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Introduction
Featured Profiles
Genmab
Geron
SpringWorks
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Small Cell Lung Cancer
Evolving Landscapes in Multiple Myeloma
OFS Summit
Multimedia
All Videos
Case-Based Exchanges
Voices From ASCO 2025
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
All Articles
Arzerra (Ofatumumab) Receives FDA Approval for Patients with Previously Untreated Chronic Lymphocytic Leukemia for Use in Combination with Chlorambucil
By
Lisa A. Raedler, PhD, RPh
Drug Updates
October 2014, Vol 4, No 6
Read More ›
FDA-Approved Medications Used for the Treatment of Breast Cancer
Breast Cancer
,
ICD Codes
October 2014, Vol 4, No 6
Read More ›
Connecting Patients to Resources
By
Sheryl A. Riley, RN, OCN, CMCN
Reimbursement
October 2014, Vol 4, No 6
Changes in our economy and healthcare system (ie, the Affordable Care Act, accountable care organizations, evolving reimbursement models) have given birth to a new member of the healthcare team: the financial advocate.
Read More ›
CMS Takes Stock of Federal Health Insurance Marketplace Benefits
By
Rosemary Frei, MSc
Practice Management
October 2014, Vol 4, No 6
Read More ›
FDA to Regulate Laboratory-Developed Tests
By
Rosemary Frei, MSc
October 2014, Vol 4, No 6
Read More ›
Do’s and Don’ts in Physician–Hospital Alignment, Part 2
By
Max Reiboldt, CPA
Practice Management
October 2014, Vol 4, No 6
Read More ›
Community–Hospital Relationships: Working Together to Define What Is Right for Patients
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
October 2014, Vol 4, No 6
Read More ›
Disaster Planning for the Oncology Office, Part 2
By
Mariana S-B Lamb, MS
Practice Management
October 2014, Vol 4, No 6
Read More ›
Bringing the Future into the Present: Disaster Planning for the Oncology Office
By
Mariana S-B Lamb, MS
Practice Management
August 2014, Vol 4, No 5
Read More ›
Defining the Boundaries of Oncology Management
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
August 2014, Vol 4, No 5
Read More ›
Page 275 of 298
272
273
274
275
276
277
278